Advertisement
Research Article

Using Plasma Viral Load to Guide Antiretroviral Therapy Initiation to Prevent HIV-1 Transmission

  • Pamela M. Murnane mail,

    pmurnane@uw.edu

    Affiliations: Department of Epidemiology, University of Washington, Seattle, Washington, United States of America, Department of Global Health, University of Washington, Seattle, Washington, United States of America

    X
  • James P. Hughes,

    Affiliation: Department of Biostatistics, University of Washington, Seattle, Washington, United States of America

    X
  • Connie Celum,

    Affiliations: Department of Epidemiology, University of Washington, Seattle, Washington, United States of America, Department of Global Health, University of Washington, Seattle, Washington, United States of America, Department of Medicine, University of Washington, Seattle, Washington, United States of America

    X
  • Jairam R. Lingappa,

    Affiliations: Department of Global Health, University of Washington, Seattle, Washington, United States of America, Department of Medicine, University of Washington, Seattle, Washington, United States of America, Department of Pediatrics, University of Washington, Seattle, Washington, United States of America

    X
  • Nelly Mugo,

    Affiliations: Department of Global Health, University of Washington, Seattle, Washington, United States of America, Department of Obstetrics & Gynaecology, University of Nairobi, Nairobi, Kenya, Department of Obstetrics & Gynaecology, Kenyatta National Hospital, Nairobi, Kenya

    X
  • Carey Farquhar,

    Affiliations: Department of Epidemiology, University of Washington, Seattle, Washington, United States of America, Department of Global Health, University of Washington, Seattle, Washington, United States of America, Department of Medicine, University of Washington, Seattle, Washington, United States of America

    X
  • James Kiarie,

    Affiliations: Department of Global Health, University of Washington, Seattle, Washington, United States of America, Department of Obstetrics & Gynaecology, University of Nairobi, Nairobi, Kenya, Department of Obstetrics & Gynaecology, Kenyatta National Hospital, Nairobi, Kenya

    X
  • Anna Wald,

    Affiliations: Department of Epidemiology, University of Washington, Seattle, Washington, United States of America, Department of Laboratory Medicine, University of Washington, Seattle, Washington, United States of America, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center (FHCRC), Seattle, Washington, United States of America, Public Health Sciences and Clinical Research Divisions FHCRC, Seattle, Washington, United States of America

    X
  • Jared M. Baeten,

    Affiliations: Department of Epidemiology, University of Washington, Seattle, Washington, United States of America, Department of Global Health, University of Washington, Seattle, Washington, United States of America, Department of Medicine, University of Washington, Seattle, Washington, United States of America

    X
  • for the Partners in Prevention HSV/HIV Transmission Study Team , for the Partners in Prevention HSV/HIV Transmission Study Team

    Membership of the Partners in Prevention HSV/HIV Transmission Study Team is provided in the Acknowledgments.

    X
  • Published: November 30, 2012
  • DOI: 10.1371/journal.pone.0051192

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.